BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/6/2021 3:03:06 PM | Browse: 34 | Download: 15
Publication Name World Journal of Clinical Cases
Manuscript ID 62978
Country/Territory China
Category Infectious Diseases
Manuscript Type Case Report
Article Title Thymosin as a possible therapeutic drug for COVID-19: A case report
Manuscript Source Unsolicited Manuscript
All Author List Qiong Na Zheng, Mei Yan Xu, Fang Min Gan, Sha Sha Ye and Hui Zhao
Funding Agency and Grant Number
Funding Agency Grant Number
Project for Science and Technology of Wenzhou Y2020278
Corresponding Author Hui Zhao, MD, Chief Doctor, Department of Infectious Diseases, The Affiliated Yueqing Hospital, Wenzhou Medical University, No. 338 Qingyuan Street, Yueqing 325600, Zhejiang, China. 304764851@qq.com
Key Words COVID-19; Thymosin; SARS-CoV-2; Case report; Treatment; Therapeutic drug
Core Tip A 51-year-old Chinese man returned from Russia to Yueqing Hospital Affiliated to Wenzhou Medical University on April 27, 2020. He had 2-wk symptoms of chest pain, chest tightness, fatigue, and conscious fever. Oxygen inhalation, and thymosin was injected twice a week, at 1.6 mg per injection. The patient was successfully treated and discharged after 15 d in the hospital.
Citation Zheng QN, Xu MY, Gan FM, Ye SS, Zhao H. Thymosin as a possible therapeutic drug for COVID-19: A case report. World J Clin Cases 2021; In press
Received
2021-01-22 16:26
Peer-Review Started
2021-01-22 16:31
To Make the First Decision
Return for Revision
2021-03-25 06:02
Revised
2021-03-28 17:32
Second Decision
2021-04-06 08:31
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-04-06 15:03
Articles in Press
2021-04-06 15:03
Publication Fee Transferred
Edit the Manuscript by Language Editor
2021-04-13 23:18
Typeset the Manuscript
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Assistant Editor Assistant Editor
Science Editor Han Zhang (Part-Time Editor)
Reviewer Code 03262105, and 05849037
Editorial Director
Journal Chief Editor
Company Chief Editor Li Ma
Language Editor Tian-Qi Wang
Production Editor
Responsible Production Editor
Responsible Science Editor
Proofing Editorial Director Jin-Lei Wang
Proofing Editor-in-Chief Lian-Sheng Ma
Manuscript File 62978_Auto_Edited_LM_WangTQ.docx
Answering Reviewers 62978-Answering reviewers.pdf
Audio Core Tip 62978-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 62978-Conflict-of-interest statement.pdf
Copyright License Agreement 62978-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 62978-Grant application form(s).pdf
Signed Informed Consent Form(s) or Document(s) 62978-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate 62978-Language certificate.pdf
Peer-review Report 62978-Peer-review(s).pdf
Scientific Misconduct Check 62978-Scientific misconduct check.pdf
Scientific Editor Work List 62978-Scientific editor work list.pdf